1 terminated, 1 unknown. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 1, Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Coronary Microvascular Disease: new trials by email Literature Review of Coronary Microvascular Disease trials Research Report on Coronary Microvascular Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Placebo-Controlled Trial of CLBS16 in Subjects With Coronary Microvascular Dysfunction CLBS16, Placebo - Coronary Microvascular Dysfunction, Coronary Microvascular Disease | Phase 2 | Terminated | Lisata Therapeutics, Inc. | 34 | 2020-10-29 | 2026-05-04 |
| Rhodiola Rosea for Coronary Microvascular Disease Rhodiola Rosea Capsules, Placebo - Coronary Microvascular Disease | Phase 2 / Phase 3 | Unknown | Qilu Hospital of Shandong University | 114 | 2020-01-01 | 2020-01-06 |
Microvascular Angina (2) · Angina Pectoris (1)
Cardiovascular Diseases (2) · Heart Diseases (2) · Myocardial Ischemia (2) · Vascular Diseases (2) · Angina Pectoris (1) · Chest Pain (1) · Neurologic Manifestations (1) · Pain (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Lisata Therapeutics, Inc. (1) · Qilu Hospital of Shandong University (1)
United States (1)